Pharmaron Beijing Co., Ltd.*

康龍化成(北京)新藥 技術股份有 限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code:3759)

Form of Proxy for the Annual General Meeting of 2020

(Applicable to H Shareholders)

Number of H shares to which this form of proxy relates(Note 1)

I/We(Note 2) (name)

of (address)

being the registered holder(s) of

(Note 3) H Shares of RMB1.00 each in the share capital of Pharmaron

Beijing Co., Ltd.* (康龍化成(北京)新藥技術股份有限公司) (the "Company") hereby appoint the Chairman of the Meeting, or(Note 4)

of (address)

as my/our proxy to attend and vote for me/us on my/our behalf as directed below, or if no such indication is given then to vote as my/our proxy thinks fit, at the Annual General Meeting of 2020 (the "AGM") to be held at 6 Tai-He Road, Economic Technological Development Area, Beijing, the PRC on Friday, May 28, 2021 at 2 p.m. or at any adjournment thereof.

ORDINARY RESOLUTIONS(Note A)

FOR(Note 5)

AGAINST(Note 5)

ABSTAIN(Note 5)

1.

Work Report of the Board of Directors for the year 2020.

2.

Work Report of the Supervisory Committee for the year 2020.

3.

Financial Statements for the year 2020.

4.

2020 Profit Distribution Plan.

5.

2020 Annual Report's full text and report summary and 2020

Annual Results Announcement.

6.

Remuneration of the Directors for the year 2021.

7.

Remuneration of the Supervisors for the year 2021.

8.

Engagement of Domestic Auditor for the year 2021.

9.

Engagement of International Auditor for the year 2021.

10.

Guarantees Quota for the year 2021.

11.

Foreign Exchange Hedging Quota for the year 2021.

15.

Authorization for Registration of the Reduction in Registered

Capital and Amendments to the Articles of Association.

SPECIAL RESOLUTIONS (note A)

12.

Repurchase and Cancellation of Part of the Restricted A Shares

Granted Under the A Share Incentive Scheme.

13.

Reduction of Registered Capital.

14.

Amendments to the Articles of Association.

16.

Granting of General Mandate to Issue A Shares and/or H Shares.

Note A: Unless otherwise specified, capitalized terms used herein shall have the same meanings as those defined in the circular dated April 28, 2021.

Date:

Signature of Shareholder(s) (Note 6):

Notes:

  1. Please insert the number of shares registered in your name(s) to which this proxy relates. If a number is inserted, this form of proxy will be deemed to relate only to those shares. If no number is inserted, the form of proxy will be deemed to relate to all shares registered in your name(s) (whether alone or jointly with others).
  2. Please insert the full name(s) and address(es) as registered in the register of members for H Shares of the Company in BLOCK LETTERS. The name of all joint registered holders should be stated.
  3. Please insert the number of shares of the Company registered in your name(s) and delete as appropriate.
  4. If any proxy other than the Chairman of the Meeting is preferred, please strike out the words "the Chairman of the Meeting, or" and insert the name and address of the proxy desired in the space provided. A shareholder may appoint one or more proxies to attend and vote at the Meeting on his/her behalf. A proxy needs not be a shareholder of the Company. Any alteration made to this form of proxy must be initialed by the person who signs it.
  5. Important: If you wish to vote for any resolution, please put a tick in the box marked "FOR". If you wish to vote against any resolution, please put a tick in the box marked "AGAINST". If you wish to vote abstention on any resolution, please put a tick in the box marked "ABSTAIN". If the form returned is duly signed but without specific direction on any of the proposed resolutions, the proxy is entitled to vote or abstain at his/her discretion in respect of all resolutions; or if in respect of a particular proposed resolution there is no specific direction, the proxy is entitled, in relation to that particular proposed resolution, to vote or abstain at his/her discretion. A proxy will also be entitled to vote at his/her discretion on any resolution properly put to the AGM other than those set out in the notice convening the EGM.
  6. This form of proxy must be signed by you or your attorney duly authorized in writing or, in the case of a legal person, must be either executed under its common seal or under the hand of its legal representative or attorney or other officer duly authorized.
  7. If an attending shareholder or proxy casts a vote of abstention or abstains from voting in respect of a resolution, the Share(s) represented by that shareholder or proxy will be regarded as valid votes when the Company counts the votes with respect to that resolution.
  8. To be valid, this form of proxy and, if such proxy is signed by a person on behalf of the appointer pursuant to a power of attorney or other authority, a notarially certified copy of that power of attorney or other authority must be delivered to the Company's H Shares Registrar in Hong Kong, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not less than 24 hours before the time for holding of the AGM (i.e. before 2 p.m. on Thursday, May 27, 2021) or not less than 24 hours before the holding of any adjournment thereof.
  9. Completion and delivery of this form of proxy will not preclude you from attending and voting at the AGM or any adjournment thereof if you so wish. In such event, the instrument appointing a proxy shall be deemed to be revoked.
  10. Shareholders or his/her proxy(ies) shall produce their identification documents when attending the AGM in person or by proxy.

* For identification purposes only

Attachments

  • Original document
  • Permalink

Disclaimer

Pharmaron Beijing Co. Ltd. published this content on 28 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2021 10:04:05 UTC.